1. Home
  2. Live Updates
  3. Gitanjali jain

Gitanjali Jain News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gitanjali jain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gitanjali Jain Today - Breaking & Trending Today

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) Apr 8, 2024 ....

United States , Gitanjali Jain , Compensation Committee , Kezar Life Sciences , Kezar Life Sciences Inc , Life Sciences , Nasdaq Listing Rule , Media Contact , Investor Relations , Business Wire ,

Kezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference

SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) Nov 21, 2023 ....

United States , Chris Kirk , Gitanjali Jain , Kezar Life Sciences Inc , Kezar Life Sciences , Life Sciences , Chief Executive Officer , Annual Evercore , Investor Contact , Investor Relations , Business Wire ,

Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) Nov 13, 2023 ....

San Diego , United States , South Korea , Rohit Aggarwal , Gitanjali Jain , Christopher Kirk , John Fowler , Exchange Commission , Clinical Development , Asia Pacific League , Kezar Life Sciences Inc , American College Of Rheumatology , University Of Pittsburgh , Society For Immunotherapy Of Cancer , Kezar Life Sciences , Life Sciences , Chief Executive Officer , Everest Medicines , Chief Scientific , Selective Immunoproteasome , Greater China , Label Extension , American College , Broad Spectrum Sec , Annual Meeting , David Bade ,

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Compensation Committee of the company’s Board of Directors granted one employee a nonq. ....

Gitanjali Jain , Kezar Life Sciences , Compensation Committee , Kezar Life Sciences Inc , Nasdaq Listing Rule , Life Sciences , Investor Relations , External Affairs ,

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) Oct 9, 2023 ....

United States , Gitanjali Jain , Compensation Committee , Kezar Life Sciences , Kezar Life Sciences Inc , Life Sciences , Nasdaq Listing Rule , Investor Contact , Investor Relations , Business Wire ,